Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Christenson

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Annals of Clinical Biochemistry|April 20, 2021
Health economic evaluations of medical tests: Translating laboratory information into value - A case study examplePaul Jülicher, Maurice O'Kane, Christopher P Price, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysisChristopher R DeFilippi, Jeffrey C Fink, Caitlin M Nass, et al.
JACC. Heart Failure|March 14, 2014
Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline riskDanielle Glick, Christopher R deFilippi, Robert Christenson, et al.
The American Journal of Cardiology|May 9, 2006
N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patientsIjaz A Khan, Jeffrey Fink, Caitlin Nass, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 9, 2021
Implementation of medical tests in a Value-Based healthcare environment: A framework for delivering valueAndrew St John, Maurice O'Kane, Robert Christenson, et al.
Biotechnology and Applied Biochemistry|December 17, 2011
The Emit® 2000 Cyclosporine Specific Assay, Extended Range: development of an application protocol for the V-Twin® analyzerNihmat Morjana, Harriet Yau, Diane Rea, et al.
Clinical Biochemistry|May 14, 2023
Proof of concept: Detection of cell free RNA from EDTA plasma in patients with lung cancer and non-cancer patientsKristin E Mullins, Chamindi Seneviratne, Amol C Shetty, et al.
Journal of Clinical Laboratory Analysis|July 19, 2022
A multicenter performance evaluation of the new Elecsys Vitamin D total III assay versus reference isotope dilution liquid chromatography tandem mass spectrometry and commercially available comparatorsPeter Findeisen, Marta Leis, Garnet Bendig, et al.
Diabetes Research and Clinical Practice|January 23, 2022
Glycated albumin and HbA1c as markers of lower extremity disease inUS adults with and without diabetesCaitlin W Hicks, Dan Wang, Kunihiro Matsushita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304Martin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Annals of Clinical Biochemistry|April 20, 2021
Health economic evaluations of medical tests: Translating laboratory information into value - A case study examplePaul Jülicher, Maurice O'Kane, Christopher P Price, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysisChristopher R DeFilippi, Jeffrey C Fink, Caitlin M Nass, et al.
JACC. Heart Failure|March 14, 2014
Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline riskDanielle Glick, Christopher R deFilippi, Robert Christenson, et al.
The American Journal of Cardiology|May 9, 2006
N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patientsIjaz A Khan, Jeffrey Fink, Caitlin Nass, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 9, 2021
Implementation of medical tests in a Value-Based healthcare environment: A framework for delivering valueAndrew St John, Maurice O'Kane, Robert Christenson, et al.
Biotechnology and Applied Biochemistry|December 17, 2011
The Emit® 2000 Cyclosporine Specific Assay, Extended Range: development of an application protocol for the V-Twin® analyzerNihmat Morjana, Harriet Yau, Diane Rea, et al.
Clinical Biochemistry|May 14, 2023
Proof of concept: Detection of cell free RNA from EDTA plasma in patients with lung cancer and non-cancer patientsKristin E Mullins, Chamindi Seneviratne, Amol C Shetty, et al.
Journal of Clinical Laboratory Analysis|July 19, 2022
A multicenter performance evaluation of the new Elecsys Vitamin D total III assay versus reference isotope dilution liquid chromatography tandem mass spectrometry and commercially available comparatorsPeter Findeisen, Marta Leis, Garnet Bendig, et al.
Diabetes Research and Clinical Practice|January 23, 2022
Glycated albumin and HbA1c as markers of lower extremity disease inUS adults with and without diabetesCaitlin W Hicks, Dan Wang, Kunihiro Matsushita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304Martin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Pageof 8